An SNP of the NPAS2 gene, rs6542993, was associated with greater risk for disease progression in patients with localized PCa, indicating the value of NPAS2 SNP as a potential biomarker for PCa progression [144]. The gene discussed is NPAS2; the disease is posterior cortical atrophy.